Recent Videos

Lunch Symposium (Mylan) - The Future of Biosimilars in Oncology - Implementing the Lessons from Today

Featuring:
Dr. Stephen Chia

GI - Colorectal and Non-Colorectal

Featuring:
Dr. Stephanie Snow

Radiation Oncology Update: Management of Oligometastases

Featuring:
Dr. Alexander Louie

Updates and Optimizing Outcomes in Non Intensive AML Management

Featuring:
Dr. Jorge Cortes
Chair:
Dr. Brian Leber

Optimizing Patient Outcomes for HER2+ Early Breast Cancer

Featuring:
Dr. Anil Joy
Dr. Olexiy Aseyev
Dr. Angel Arnaout
Alia Thawer
Chair:
Dr. Sonal Gandhi

Critical Role of Treating Minimal Residual Disease in Acute Lymphoblastic Leukemia

Featuring:
Dr. Nikola Gokbuget
Chair:
Dr. Andre Schuh

A Decade of Systemic Treatments of Hepatocellular Carcinoma: From a Myth to a Central Role

Featuring:
Dr. Ghassan Abou-Alfa
Chair:
Dr. Sharlene Gill

Drug development in Immuno-Oncology

Featuring:
Dr. Jason Luke

Biomarkers in Immuno-Oncology

Featuring:
Dr. Rosalyn Juergens

Cellular Therapies: Clinical Overview

Featuring:
Dr. Michael Chu

Cellular Therapies: Production and Challenges

Featuring:
Dr. Brad Nelson

Cellular Therapies: Q&A

Featuring:
Dr. Michael Chu and Dr. Brad Nelso

GI - Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

Common Adverse-Events

Featuring:
Dr. Ralph Wong

Uncommon Adverse-Events

Featuring:
Dr. Jose Monzon

Implementation of Biosimilars in Clinical Practice: Cost, Ethics, and Nuances

Featuring:
Dr. Scott Berry
Dr. Christine Brezden-Masley
Dr. Stephen Chia
Dr. John Hilton
Dr. Scott Edwards
Swanee Tobin

The evolving treatment landscape of advanced cSCC

Featuring:
Dr. Teresa Petrella
Chair:
Dr. Gary Groot

Defining the Standard of Care in NSCLC

Featuring:
Dr. Marina Garassino
Dr. Randeep Sangha

CheckMate 649, ATTRACTION-4, KEYNOTE-062, KEYNOTE-590 and CheckMate 577

Gastroesophageal Cancer
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 and PRODIGE 13

GI Colorectal
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Disparities in Cancer during the COVID-19 Pandemic: CCOS Study

Featuring:
Dr. Sheena Bhalla

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

Impact of COVID-19 on management of cancer treatments & psychological consequence for patients

Featuring:
Dr. Florence Joly

KEYNOTE-590 Study

Featuring:
Dr. Ken Kato

CheckMate 577 Study

Featuring:
Dr. Ronan Kelly

CheckMate 649 study

Featuring:
Dr. Markus Moehler

Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection (COVID-19 Data)

Featuring:
Dr. Trisha Wise-Draper

HAIC with FOLFOX vs. TACE for unresectable HCC

Featuring:
Dr. Ming Shi

The Canadian Cancer Trials Group PA.7 Trial

Featuring:
Dr. Daniel Renouf

Clinical & lab prognostic factors in patients with cancer and SARS-CoV-2 infection: CCC19

Featuring:
Dr. Petros Grivas

The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLAA

Featuring:
Dr. Pia Kvistborg

KEYNOTE-177 Study

Featuring:
Dr. Thierry André

The Impact of COVID-19 on Oncology Professionals: Initial Results of The ESMO Resilience Task Force Survey Collaboration

Featuring:
Dr Susana Banerjee

Outcome and prognostic factors of SARS CoV-2 infection in cancer patients

Featuring:
Dr. Markus Joerger

ESMO 2020 Virtual Data Watch - GI

Application of Biosimilars in Clinical Care: Potential Opportunities and Barriers

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Sandeep Sehdev

Debate: What is the optimal endpoint in adjuvant lung cancer trials evaluating target treatments?

Featuring:
Dr. Roy Herbst &
Dr. Jack West
Chair:
Dr. Frances Shepherd

Understanding the Approach to Managing Skin Toxicities Associated with Managing mCRC

Featuring:
Dr. Mario Lacouture
Chair:
Dr. Nathan Lamond

Real World Experience in the EU with Biosimilars

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Bruce Colwell

Panel Discussion: Does the Primary Matter? - Moving Towards a Tumour-Agnostic Approach

Featuring:
Dr. Gwyn Bebb
Dr. Stephen Yip
Dr. Janessa Laskin

Cancer Care in COVID-19 Era

Featuring:
Dr. Sharlene Gill

Colorectal GI Cancer

Featuring:
Dr. Jonathan Loree

Non-Colorectal GI Cancer

Featuring:
Dr. Patricia Tang

Supportive Care

Featuring:
Dr. Elie Kassouf

Practice Changing Data

Featuring:
Dr. Kim Ma

Non-Colorectal GI Cancer

Featuring:
Dr. Frédéric Lemay

Colorectal GI Cancer

Featuring:
Dr. Petr Kavan

The Cancer and the Virus: How to Treat One While Keeping the Other One at Bay - The Quebec Strategy

Featuring:
Dr. Jamil Asselah

Does treatment sequencing matter in metastatic colorectal cancer?

Featuring:
Dr. Julien Taieb
Chair:
Dr. Scott Berry

Lunch Symposium - Update on Treatments for Advanced RCC: Making Choices Using Script Concordance Theory

Featuring:
Dr. Aly-Khan Lalani

Canadian Achievements in Cancer Research

Featuring:
Dr. Natasha Leighl
Dr. Stephen Chia

Colorectal GI Cancers

Featuring:
Dr. Sharlene Gill

Non-Colorectal GI Cancers

Featuring:
Dr. Grainne O'kane

CodeBreak 100 & Prevalence of KRASG12C Mutations Utilizing ctCDA

KRAS G12C Mutations

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

KEYNOTE-177 & Pembrolizumab Monotherapy in MSI-H Pts

MSI-H Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

NTRK-FP Solid Tumors - Integrated Analysis & Larotrectinib in Pts with TRK Fusion

NTRK Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

BLU-667 in RET Fusion+ Solid Tumors

RET Fusion+ Solid Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

DESTINY-CRC01

Her-2 Positive Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

PETRARCA, NRG/RTOG 1010 & RAMSES/FLOT7

Periporative/Neoadjuvant Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

SWOG S1505 & ESPAC 5F

Pancreatic Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

DESTINY-Gastric01

Metastatic Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

RAPIDO, UNICANCER PRODIGE 23 & OPRA

Rectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 & PANDA

Metastatic Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

IDEA, CALGB/SWOG 80702 & JCOG0603

Adjuvant Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

MEDETREME Trial

Featuring:
Dr. Francois Ghiringhelli

ASCO20 Virtual Data Watch: GI Cancers

Esophago-Gastric Cancer

Featuring:
Dr. Elena Elimova

Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty

Colorectal Cancer

Featuring:
Dr. Scott Berry

Case-Based Presentation in GI Cancers

Featuring:
Dr. Suneil Khanna

GI Faculty Panel Discussion and Q&A

Featuring:
Dr. Scott Berry
Dr. Mark Doherty
Dr. Yoo-Joung Ko
Dr. Suneil Khanna

GI Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill